About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,735 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,735 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4381-4400 of 17,735 trials

CompletedVaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Vaccines made from a patient's white blood cells may make the body build an immune response to kill cancer cells.NCT00015977·Chicago, Illinois CompletedPrognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by SurgeryRATIONALE: Prognostic testing for early signs of metastases may help doctors detect metastases early and plan more effective treatment.NCT00003901·Mobile, Alabama and 57 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

CompletedSuprazygomatic Maxillary Nerve Block in Cleft Palate OutcomesIncreased pain after cleft palate surgery is the leading cause of increased hospital length of stay, delayed oral intake, readmission, and respiratory compromise.NCT04909619·Chicago, Illinois

TerminatedEfficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic SeizuresThe primary aim of Part A of the study to assess the efficacy and tolerability of GWP42003-P compared to placebo as an adjunctive treatment for children with Epilepsy with…NCT05288283·Birmingham, Alabama and 13 others

CompletedStrategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy TrialCOVID-19 can trigger a dysregulated immune response, and previous studies have shown that immune modulation can improve outcomes in hospitalized patients.NCT05822583·Birmingham, Alabama and 126 others

CompletedA Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal FunctionThis is a phase 1, open-label pharmacokinetic study where up to 40 subjects with advanced solid tumors (up to 6-10 with normal renal function and up to 18-30 with varying degrees…NCT01331941·Atlanta, Georgia and 3 others

CompletedPhase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid TumorsThe primary objective of this study is to determine the safety, tolerability, maximum tolerated dose (MTD) or recommended Phase 2 dose (RP2D) and efficacy of rogaratinib in…NCT03517956·Los Angeles, California and 19 others

CompletedRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)This research is looking at two conditions, Essential Thrombocythemia (ET) and Polycythemia Vera (PV).NCT01259856·Scottsdale, Arizona and 24 others

CompletedA Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.NCT01770951·Dunwoody, Georgia and 22 others

CompletedA Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCTAn Open-Label and Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of SER-155 in Adults Undergoing…NCT04995653·Gilbert, Arizona and 12 others

Active not recruitingPilot Remote Therapeutic Monitoring in Cancer PatientsThe goal of this clinical trial is to learn about exercise and physical activity in individuals who are undergoing cancer treatment.NCT07007039·Chicago, Illinois

CompletedCMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib"This is a single-arm, open-label, multi-center study of complete molecular response (CMR) in adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic…NCT01227577·Anaheim, California and 31 others

CompletedRasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.Study to look at the effectiveness, tolerability and safety of two doses of Rasagiline (0.5 mg and 1mg) in advanced Parkinson's Disease (PD) Patients who have been treated with…NCT00203177·Fresno, California and 7 others

CompletedARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentThis multi-center, randomized, double-blind, placebo-controlled, parallel-group study will investigate the efficacy and safety of RO4995819 as adjunctive therapy in patients with…NCT01457677·Phoenix, Arizona and 91 others

Active not recruitingS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy DurationPatients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2.NCT04071457·Anchorage, Alaska and 841 others

CompletedFirst in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell CancersThe purpose of this study is to assess the safety and tolerability of BMS-936564 (MDX-1338) in relapsed Acute myelogenous leukemia (AML) and other selected B-cell cancers and to…NCT01120457·Birmingham, Alabama and 10 others

TerminatedPROMINENT-Eye Ancillary Study (Protocol AD)Despite improved glycemic and systemic control for many patients with diabetes, over the past several decades, diabetic retinopathy (DR) develops and progresses in a large…NCT03345901·Phoenix, Arizona and 70 others

CompletedBilingual Electronic Symptom Management Program Across Multi-site, Comprehensive Cancer CenterCancer, and cancer treatment, cause many symptoms that can negatively affect quality of life.NCT03988543·Chicago, Illinois

CompletedChronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back PainThe purpose of this study is to test whether LY3526318 is efficacious and safe in relieving chronic low back pain (CLBP).NCT05086289·Chandler, Arizona and 30 others

CompletedEffect of LY450139 on the Long Term Progression of Alzheimer's DiseaseAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00594568·Birmingham, Alabama and 147 others

PreviousPage 220 of 887Next

in Chicago

Heart Diseasein Chicago